Bayesian models are increasingly fit to large administrative data sets and then used to make individualized recommendations. In particular, Medicare's Hospital Compare webpage provides information to patients about specific hospital mortality rates for a heart attack or Acute Myocardial Infarction (AMI). Hospital Compare's current recommendations are based on a random-effects logit model with a random hospital indicator and patient risk factors. Except for the largest hospitals, these individual recommendations or predictions are not checkable against data, because data from smaller hospitals are too limited to provide a meaningful check. Before individualized Bayesian recommendations, people derived general advice from empirical studies of many hospitals; e.g., prefer hospitals of type 1 to type 2 because the risk is lower at type 1 hospitals. Here we calibrate these Bayesian recommendation systems by checking, out of sample, whether their predictions aggregate to give correct general advice derived from another sample. This process of calibrating individualized predictions against general empirical advice leads to substantial revisions in the Hospital Compare model for AMI mortality. In order to make appropriately calibrated predictions, our revised models incorporate information about hospital volume, nursing staff, medical residents, and the hospital's ability to perform cardiovascular procedures. For the ultimate purpose of comparisons, hospital mortality rates must be standardized to adjust for patient mix variation across hospitals. We find that indirect standardization, as currently used by Hospital Compare, fails to adequately control for differences in patient risk factors and systematically underestimates mortality rates at the low volume hospitals. To provide good control and correctly calibrated rates, we propose direct standardization instead.
1 Are Mortality Rates For AMI Lower at Some Hospitals?
Individualized Bayes Predictions Should Calibrate with Sound, EmpiricallyBased General Advice
With a view to providing the public with information about the quality of hospitals, Medicare runs a website called "Hospital Compare" (http://www.medicare.gov/hospitalcompare/). Among other things, for each hospital, Hospital Compare provides information about the mortality rate of patients treated for a heart attack, or "acute myocardial infarction" (AMI). If you enter your zip code at the website, Hospital Compare will tell you about hospitals near where you live.
Nationally, for a person who arrives at the hospital alive, the 30 day mortality rate following AMI is in the vicinity of 15%. The website's reported hospital-specific mortality rates are based on Medicare claims data and a random effects logit model in which hospitals enter as a random intercept and adjustments are made for risk factors describing individual patients, for instance age and prior heart attacks. The number reported by Hospital Compare is essentially an indirectly standardized mortality rate for each hospital, adjusting for measured risk factors describing the patient. An indirectly standardized rate is a constant multiple of a ratio of two predictions for the mortality of the patients actually treated at that hospital, namely, in the numerator, the model's predicted mortality rate if these patients were treated at this hospital, and in the denominator, the model's predicted mortality for the same patients if treated at what Hospital Compare considers to be a "typical" hospital. A ratio substantially above one is interpreted as "worse than average risk" and a ratio substantially below one is interpreted as "better than average risk". The website describes most hospitals as "no different than the national average." Some small hospitals treat a few AMIs per year, whereas there is a hospital in New York that treats on average about two AMIs per day. Mortality rates from small hospitals are quite unstable, and the random intercepts model used by Hospital Compare shrinks these rates to resemble the National average. Their model says: "if there is not much data about your hospital, then we predict it to be average." For any one small hospital, there is not much data to contradict that prediction. So their model claims that the mortality rate at each small hospital is close to the National average. Is this a discovery or an assumption?
If it is a discovery, then it is a surprising discovery. A fairly consistent finding in health services research is that, adjusting for patient risk factors, mortality rates are typically higher at low volume hospitals (Gandjour, So, is the finding of average risk at small hospitals a discovery or an assumption? Actually, it is neither: it is a mistake. The model is not properly calibrated; see Dawid (1982) for discussion of calibration. Although there is very little data about any one small hospital, hence very little data to check a statement about one small hospital, there is plenty of data about small hospitals as a group. When Hospital Compare's predictions for all small hospitals are added up, it is unambiguously clear that the risk at small hospitals as a group is well above the national average; see Silber et al. (2010) .
There is, here, a general principle. A Bayesian model can use all of the data to make an individualized prediction that is difficult to check as a single prediction. It is possible that this individualized prediction is better than relying upon general advice, because it is possible that this individualized prediction is tapping into distinctions evident in the data but not reflected in general advice. But if the general advice is correct as general advice, the individualized predictions should not aggregate to contradict it. As a check on whether a Bayesian model is 
Outline: Modeling, Calibrating and Reporting Hospital Mortality Rates
In the current paper, we show how the Hospital Compare model can be elaborated to yield improved predictions that no longer contradict general advice. We confirm such improvements by fitting the model in one sample and making predictions for another: in particular, we predict the outcome of the general advice that would be obtained from the second sample by an empirical study that made no use of the model. For the public reporting of these improved predictions, we propose a direct standardization approach that is effective at adjusting hospital mortality rate comparisons for patient mix differences between hospitals.
In Section 2, we apply a Bayesian implementation of the Hospital Compare model to recent Medicare data for AMI, obtaining results similar to those reported on the Hospital Compare webpage. Observing how it treats the various sources of mortality rate variation, we then consider, in Section 3, whether the Hospital Compare model adequately describes the data. Specifically, in Section 3, we describe a sequence of hierarchical random effects logit models predicting AMI mortality from attributes of patients prior to admission, such as age, prior MI, and diabetes, and from the identity and attributes of individual hospitals, such as a hospital's volume, its capabilities in interventional cardiology and cardiac surgery, and the adequacy of its support staff in terms of nurses and residents. We also consider an interaction between a patient attribute and a hospital attribute, so the model becomes able to say that the best hospital for one patient may differ from the best hospital for another patient.
The models are evaluated in Section 4.1 on the basis of predictive Bayes factors which gauge their ability to make out-of-sample predictions. Then Section 4.2 checks whether the models are calibrated by (i) performing matched studies of general advice using out-of-sample data, studies that make no use of the model, and (ii) using the model's out-of-sample predictions to predict the results of those matched studies. In other words, the model's individualized predictions are aggregated to predict the results of a study that might have been used to generate general advice without individualized predictions. Some models are much better calibrated than others.
We turn to standardization for public reporting in Section 5. The parameters of a Bayesian model would be difficult for the public to understand. Hospital Compare reports indirectly standardized rates. We contrast and evaluate directly and indirectly standardized rates. We conclude that indirectly standardized rates should not be used for public reporting, but directly standardized rates work well. In Section 6, we describe what can be learned from our recommended approach to hospital mortality rate estimation. This includes mortality rate uncertainty intervals, classification of hospitals by Low, Average and High mortality rates, and the influence of hospitals attributes on mortality. Section 7 concludes with a discussion. In supplemental appendices, we provide technical aspects of our Bayesian computational approach, as well as extensions and details of the various analyses considered throughout.
Hierarchical Bayesian Models for Adjusted Mortality Rates

The Data
Our data were obtained from Medicare records on N = 377, 615 AMI cases for patients admitted to H = 4, 289 hospitals from July 1, 2009 to December 31, 2011 . The first two years of data, up to June 30, 2011 , were used to fit the models under consideration here and in Section 3. The remaining six months of data were then used for the model validations in Section 4. We will refer to these two datasets as the training data and the validation data respectively.
Each case in our data contains an indicator of patient death within 30 days of admission, patient-specific demographics and risk factors (gender, age, history of diabetes, etc.), and hospitalspecific attributes (volume, number of beds, etc.) We denote these variables as follows. For patient j in hospital h, j = 1, 2, . . . , n h and h = 1, 2, . . . , H, let y hj ∈ {0, 1} be the binary outcome for whether the patient died (y hj = 1) or did not die (y hj = 0) within 30 days of admission. Let x hj and z h be the accompanying vectors of patient attributes and hospital attributes, respectively.
The number of patients per hospital n h varied a great deal over our data, ranging from 1 to 2782 patients, with a median value of 79. The three year volume of all Medicare AMI admissions at hospital h, which we denote vol h , is a particular characteristic that will turn out to figure prominently in our modeling of mortality rates throughout.
The Hospital Compare Random Effects Model
To motivate the modeling of mortality rates for our Medicare data, let us begin with Figure 2 .1, a plot of the raw observed hospital mortality rates O h = 1 n h j y hj by volume vol h . As would be expected, O h variation is largest at low volume hospitals where n h is small, and then steadily decreases as hospital volume increases. Also evident in the plot is a steadily decreasing average mortality rate, summarized by a smoothing spline, which is highest at low volume hospitals. This spline crosses the overall average patient mortality rate lineȳ = 0.1498 at a hospital volume of about 450. An issue of central interest is the extent to which this average patient mortality rate curve can be explained by patient attributes and/or hospital characteristics. Here, P (Y hj = 1) = p hj = logit −1 (α h + x hj β) is the hjth patient's underlying 30-day mortality rate, which is determined by a hospital effect α h and a patient effect x hj β. The hospital effects α h are modeled as independent normal random effects drawn from a single normal distribution which does not depend on any hospital attributes. On the other hand, the patient effects x hj β, which explicitly depend on patient attributes x hj , are transmitted through a common fixed effect vector β. Under this model, the underlying average 30-day mortality rate for patients treated at hospital h is given by
To mesh with our labeling of models proposed later in Section 3.2, we will refer to the Hospital
Compare model (2.1)-(2.2) as the (C,C) model because it constrains both the mean and the variance of the α h distribution to be constant.
For the implementation of this (C,C) model, we propose a fully Bayesian approach with the relatively noninfluential, neutral conjugate priors With such a fully Bayes model, all inferences about mortality rates, hospital effects, patient effects, and functions of these, can be obtained from the posterior distributions π(p | y), π(α | y)
and π(β | y), where p, α, β and y are the complete vectors of mortality rates, hospital effects, fixed effects and observed mortality indicators, respectively. In particular, we use posterior meansp,α andβ as estimates throughout, with 95% posterior density intervals to describe their uncertainty.
As described in Appendix A.1, these can all be efficiently computed by Markov Chain Monte Carlo Nevertheless, it appears that substantialP h variability of remains, especially at the small volume hospitals where n h in (2.3) is small.
Insight into the source of theP h variability under the (C,C) model is obtained from Figure   2 .3a, a plot of theα h posterior mean estimates by vol h . Whereas theP h manifest larger variation at the low volume hospitals, as well as an elevated and decreasing average mortality rate, theα h manifest exactly the opposite behavior, (though on a different scale than theP h ). The variation of theα h is smallest at the low volume hospitals, where the averageα h smoothing spline is flat and unrelated to hospital volume. Since α h and x hj β are the only components of p hj in (2.1), the variation of the (C,C) modelP h at the low volume hospitals is being driven almost entirely by the variation of patient effects x hj β, j = 1, . . . , n h across hospitals. Thus, under the (C,C) model, the elevated average mortality rates at the lower volume hospitals is coming from a riskier patient case-mix distribution at those hospitals rather than from hospital effect differences. A primary purpose of the Hospital Compare analysis is to adjust for patient case-mix variation with an indirect standardization of the hospital mortality estimates. This standardization effectively eliminates all mortality rate differences between the low volume hospitals as will be seen in Figure 5 .1a of Section 5. As discussed in Section 1, such a conclusion is at odds with the general finding in the literature that patient risk-adjusted mortality rates are typically higher at low volume 3 Hierarchical Modeling of the Random Hospital Effects
The Illusion of Safe Shrinkage Estimation
The absence of an elevated level of low volume hospital effects in Figure 2 .3a turns out to be an artifact of the (C,C) model, as will be seen by comparison with alternative models. In leaving hospital characteristics out of the model and treating the α h 's as independent of volume vol h , the (C,C) model has not allowed the data to speak to this possibility. Indeed, the pattern in Figure   2 .3a is consistent with the strong random effects assumption (2.2) of normally distributed α h 's with a common mean µ α and variance σ 2 α . Under such a normal prior, we would expect all thê α h estimates to be shrunk towards a single common mean. Such shrinkage would be especially pronounced for thoseα h for which there is less sample information, namely theα h 's for the low volume hospitals. This is exactly what we see.
Although shrinkage estimation has the potential to improve noisy estimates, such as the raw small hospital mortality rates in our setting, it can only do so if the shrinkage targets, here the means of the α h 's, are appropriately specified. Contrary to the commonly held belief that shrinkage estimation can do no harm, which can be the case in certain stylized contexts, shrinkage estimation with a model that is at odds with the data can be very detrimental. With an unforgiving, nonrobust normal prior that imposes strong shrinkage, the resulting estimates will be poor and misleading if shrinkage targets are incorrectly specified; see Berger (1985) .
The evident and plausible relationship between mortality rates and volume suggests that it would be more reasonable to shrink mortality rates towards the mean rates of hospitals with similar volumes. Unfortunately this does not happen with the random effects distribution (2.2) which shrinks all rates towards a single overall rate.
Modeling the Random Hospital Effects
The key to the development of a better hierarchical Bayes model for our data is to elaborate the random effects distribution (2.2) in a way that will allow the data to inform us of any potential relationship between hospital mortality rates and volume and hospital attributes such as volume.
For this purpose, we propose hierarchical logit model formulations of the form
where p hj = P (Y hj = 1) is the hjth patient's underlying 30-day mortality rate. As in (2.1), logit(p hj ) in (3.1) is still the sum of a hospital effect α h plus a fixed effect x hj β. However, (3.2) now allows the mean µ h (z) and the variance σ 2 h (z) of the hospital effects distribution to be functions of the hospital attributes z. As before, the fixed effects x hj β in (3.1) still account for patient risk variation via the patient attributes x hj , but the random effects distribution N (µ h (z), σ 2 h (z)) in (3.2) now allows the α h 's to more fully account for hospital-to-hospital variation via the hospital attributes z. Note that as a matter of convenience, we have separated the roles of x hj in (3.1) and z in (3.2) to be consistent with their variation at the patient and hospital levels respectively.
Because hospital attributes z do not vary within hospitals, this partition avoids their inclusion within the patient level linear component (3.1), where modeling their effects would be complicated by the collinearity of the intercept estimates with hospital attributes deployed at the patient level.
We now proceed to consider specific formulations for µ h (z) and σ 2 h (z) that yield better calibrated predictions for our data. As noted earlier, we refer to the Hospital Compare (2.1)-(2.2) specification of (3.1)-(3.2), namely the one for which µ h (z) ≡ µ α and σ 2 h (z) ≡ σ 2 α , as the ConstantConstant (C,C) model. Each of the formulations proposed below will be a relaxation which nests the (C,C) model as a special case, thereby allowing the data to ignore the hospital attributes if they do not lead to better predictions. Thus, these formulations will let the data speak rather than override what the data have to say.
Modeling α h as a Function of Volume
To shed light on the issue of whether hospital mortality rates are related to volume after accounting for patient mix effects, we begin by considering formulations for the mean and variance of the α h hospital effects in (3.2) as functions of the hospital attribute volume vol h only. We begin with a simple linear specification, and then proceed to consider a more flexible model which allows for a more refined description of the underlying relationship. This flexible formulation will then serve as a foundation for the further addition of hospital covariates and interactions to our final model in Section 3.4.
Before proceeding, we should emphasize that, although the application of our models will be seen to unambiguously reveal a strong association between high hospital mortality rates and low volume hospitals, we are not addressing the issue of whether this relationship is causal. Our goal is mainly to confirm the aforementioned finding of such an association in the literature, and to show that by including hospital volume in our models, we get better and more informative predictions with the Medicare data. Such predictions will help guide patients towards safer hospitals.
To provide further insight into the relationship between mortality rates and hospital size, we also examined the relationship between mortality rates and beds2008, the number of beds in 2008, a hospital attribute that is indisputably exogenous to our observed mortality rates. As shown in Appendix A.3 of the Supplemental material, a strong association between these two variables persists.
A Simple Linear Emancipation of the Means
We begin with perhaps the simplest elaboration of the mean and variance functions for (3.2), with this specification, we add the conjugate fixed effect prior (2.4) for β, and add the conjugate hyperparameter priors
where g and σ 2 α are apriori independent. We will refer to the hierarchical logit model formulation with this Linear-Constant specification as the (L,C) model. Note that the (L,C) model nests the (C,C) model as the special case for which γ 1 = 0.
Application of the (L,C) model to our data produced the hospital mortality rate and hospital effect estimatesP h andα h displayed in Figures 2.2b and 2.3b. We see immediately that compared to their (C,C) counterparts in Figure 2 .2a, the (L,C)P h 's are generally higher at the lower volume hospitals where the average rate smoothing spline has been raised substantially. This is evidently a consequence of their componentα h 's in Figure 2 .3b, which are dramatically different from their (C,C) counterparts in Figure 2 .3a. The (L,C)α h 's are now substantially higher at the low volume hospitals, with a clear downward sloping linear trend in log(vol h + 1) summarized by the superimposed smoothing spline. With a posterior mean estimateγ 1 = −0.106 and a 95% credible interval (−0.116, −0.096), the data have expressed an unambiguous preference for a downward sloping (L,C) mean specification (3.3) over the (C,C) constant specification (2.2) for which γ 1 = 0.
As will be seen with the more formal predictive model comparisons in Section 4.1, the (L,C) model P h improve very substantially over their (C,C) counterparts.
A Spline-Log-Linear Emancipation of the Means and Variances
With only a simple linear relaxation of the mean function, the (L,C) model released volume to reveal higher mortality rates explained by dramatically higher hospital effects at the low volume hospitals. To further release the explanatory power of volume, we consider a more flexible relaxation of both the mean and variance functions. In particular, we consider a spline specification for µ h (z) coupled with a log linear specification for σ 2 h (z). For the spline mean specification, let v = (log (vol 1 + 1) , . . . , log(vol H + 1) be the vector of all hospital specific volumes. We construct a B-spline basis of degree d and number of knots κ, represented by the columns of
where γ S is a k × 1 vector of spline regression coefficients. To this we add a prior on γ S of the
where P is a banded matrix that penalizes second-order differences between adjacent spline coefficients, and g S serves as a roughness penalty that determines the wiggliness of the resulting 
which nests the previous case σ 2 h (z) ≡ σ 2 α when δ = 0. To this we add the prior 8) and then complete the entire Bayesian specification of (3.5)-(3.6)-(3.7)-(3.8) with
where g S , g δ and σ 2 α are all assumed apriori independent. We will refer to the hierarchical logit model formulation with this Spline-LogLinear specification as the (S,L) model. 
Adding Further Hospital Attributes and Interactions to the Model
With our (S,L) model as a foundation, we now consider enlarging the model to incorporate further hospital attributes. This is most simply done by adding them as linear terms to µ h (z) in (3.5).
This yields the spline-linear mean specification
where z h is an r × 1 vector of hospital h attributes and γ L is an r × 1 vector of linear regression coefficients. This form is then completed with the priors
where g S and g L are priori independent of each other and of σ 2 α ∼ IG(1, 1). Going further, hospital attributes can also be incorporated as patient-hospital interactions of the form x hj * z h , products of particular attributes in x hj and z h , respectively. Because the values of such interaction terms vary at the patient level, these would be added as covariates to the linear fixed effects part of the model. Without such interactions, the model would say that one hospital, h, is either better or worse than another, h , for every patient. Of course, there is no reason to restrict attention to models with this feature and no reason to expect the world to be well described by such a model. Patient-hospital interactions remove this limitation.
Keeping the log-linear variance formulation (3.7)-(3.8), we shall refer to the hierarchical logit formulation with this Spline-Linear-Interaction specification as the (SLI,L) model. Applying an instance of this model to our data, we added three hospital attributes named NTBR, RTBR and PCI as linear terms in (3.10). The Nurse-to-Bed-Ratio (NTBR) and the Resident-to-Bed-Ratio (RTBR) are continuous hospital variables that describe the density of support staff at a hospital.
The binary hospital variable PCI is a catch-all for the ability of a hospital to perform any of the following procedures: percutaneous coronary interventions such as percutaneous transluminal coronary angioplasty (PTCA), a stent, or a coronary artery bypass graft (CABG) surgery. The ability to perform these procedures is common in large volume hospitals and much less common in small volume hospitals.
We also added a patient-hospital interaction, age hj * log(vol h + 1), appending it to x h as an additional covariate for the fixed effects term x hj β. With this interaction, the model may provide mortality rate estimates which favor one hospital for a younger Medicare patient, say aged 68, and a different hospital for another older Medicare patient, say aged 90.
Application of this particular (SLI,L) model to our data produced the hospital rate and effect 
Further Potential Elaborations
As will be confirmed in Section 4, our (L,C), (S,L) and (SLI,L) models have served to reveal the inadequacies of the (C,C) model. Paving the way for further improvements, these hierarchical elaborations of the random effects model are hardly the end of the story. Indeed, it is clear that many further elaborations may be promising, for example, by adding more hospital attributes as linear terms, spline terms or patient-hospital interactions. One might also consider elaborations of the log-linear variance specification (3.7) that include more hospital attributes, for example Posterior predictive likelihoods are obtained by averaging the probability of the validation data with respect to a data-updated "prior" distribution using the training data. Here, the predictive likelihood for model M is obtained as 
Evaluation of the predictive Bayes factor is obtained by Monte Carlo integration of the posterior predictive Bayes likelihoods using posterior parameter samples from the MCMC output, as described in Section A.1, based on the training data. Using the simulated values
, these approximations to the posterior predictive likelihoods are obtained by the empirical averages
The log posterior predictive Bayes factors comparing each of the (L,C), (S,L), (SLI,L) models with the (C,C) model are reported in Table 4 .1. The predictive improvement over the (C,C)
model by every one of our models is very large. Beginning with the (L,C) model, which simply allowed hospital effect means to be linear in volume rather than constant, the predictive likelihood increased by a huge factor of e 27.54 . Each subsequent elaboration led to a further increase -moving from linear to spline-log-liner in volume (S,L), adding three hospital covariates and a patientvolume interaction -culminating in a predictive likelihood increase of e 37.96 for our (SLI,L) model, which was the very best.
27.54 32.13 37.96 Table 4 .1: Out-of-sample log posterior predictive Bayes factor comparisons to the (C,C) model.
Out of Sample Calibration of Aggregated Individual Predictions Against Empirical Studies of General Advice
The Bayesian model predicts future mortality rates at individual hospitals. For many hospitals, there are too few AMI patients to permit a serious test of the model's predictions at that hospital.
Here, we calibrate the model by comparing its predictions to the general advice people would otherwise fall back on if individualized predictions were not available. Specifically, we conduct an out-of-sample observational study checking the general advice; then, we determine which models predict the results of that observational study with reasonable accuracy.
To illustrate, we consider the advice that one should avoid hospitals that rarely treat AMI.
As noted earlier, the literature strongly suggests this is good general advice, although it is difficult to know whether it is good advice for any single hospital that treats few AMIs -after all, such a hospital provides few patients upon which to base a mortality rate.
Using the validation sample that was not used to build the model, we look at the 20% of hospitals with the lowest volume. Before discussing the results of this comparison, a few words of caution are needed. In every observational study, there is reason to be concerned that some important covariate has not been measured, so that a comparison that corrects for measured covariates will not correctly estimate the effect under study. This is a genuine problem in ranking hospitals, and the best solution is to Table 4 .2 gives covariate means before and after matching, together with differences in means as a fraction of the standard deviation before matching. Notably, the patients at low and high volume hospitals differed substantially prior to matching, but were similar in matched samples.
Patients at low volume hospitals were older on average (84 versus 78 years old), with a higher estimated mean probability of death based on patient risk factors (.22 versus .13), a higher proportion of dementia (22% versus 12%), a higher proportion with a history of pneumonia (24% versus 12%), and a somewhat higher history of congestive heart failure (21% versus 14%), all factors that generally increase mortality risk. Patients at low volume hospitals also had a lower history of prior percutaneous transluminal coronary angiography (prior PTCA) or stenting procedures involving the heart (6% versus 16%), the history of which generally lowers risk; lower rates of documented artherosclerosis, a cardiac risk factor; and lower rates of anterior infarction, a factor also generally associated with worse prognosis. Part of the difference in mortality between low and high volume hospitals reflects the sicker patient population at low volume hospitals; however, the matching has made an effort to remove this pattern to the extent that it is visible in measured covariates.
The final two columns of Table 4 .3: Out-of-sample predicted mortality compared against observed mortality in the matched observational study of low and high volume hospitals.
observational study to provide general advice. As seen in for an AMI at a large volume hospital because the mortality rates are lower for patients who look similar in measured covariates describing patients prior to admission.
The remainder of Table 4 .3 sets aside the actual out-of-sample mortality, and instead uses the Bayes models to predict the mortality of the very same patients used in the matched observational study. Let us consider which Bayes models come close to correct predictions, making individual predictions that aggregate to agree with empirically based general advice.
The (C,C) model is very inaccurate in its predictions. That model assumed hospital mortality is independent of volume, and its predictions agree with its assumptions rather than with the out-of-sample data. It says, incorrectly, that mortality is only slightly elevated at low volume hospitals, and it also overstates the mortality at high volume hospitals. In sharp contrast, every one of the other models agree with the general advice that risk is elevated at low volume hospitals. Compared to the (C,C) model, their aggregate predictions are much closer to the actual mortality levels of both the low volume hospitals and their matched counterparts at the high volume hospitals. It is interesting to note that although the overall out-of-sample performance of the (L,C) model was the weakest of the non-(C,C) models in Table 4 .1, its aggregate predictions for the low volume hospitals were better than the rest here. A second illustration of our general out-of sample calibration approach is presented in Appendix A.3.
The lessons of Table 4 .3 are summarized below.
• It is important to check models against data in a manner that is capable of judging their inadequacies. In the current context, it is difficult to judge that a model is inadequate by predicting the mortality experience of three patients at a hospital whose total AMI volume is three patients. Something else needs to be done to check such predictions.
• It is important to check aspects of models that we actually care about. A spline is an approximation and no one really cares whether it is true or false; rather, we care whether it is adequate or inadequate as an approximation for something else that we do really care about. In the current context, we care about model predictions that might both affect hospital choice and patient mortality. In particular, a model that says low volume hospitals are safe for AMI treatment when they are not, is a model that is failing in a way that we actually care about.
• A good model for individualized predictions should produce predictions that are, in aggregate, consistent with sound empirically based general advice that we would otherwise fall back on in the absence of individualized predictions. The model should correctly predict the results of sound, out-of-sample studies of general advice that make no use of the model.
In Table 4 .3, our models do this, and the (C,C) model does not.
• It is popular to associate Stein's paradox with Bayes inference, but they actually point in different directions. Stein's paradox is a paradox because it seems to say that shrinkage is never harmful providing at least three parameters are estimated; however, it actually refers to a very special situation. In contrast, there is nothing in Bayes inference that suggests one will get the right answer by assuming things that are false or by fitting the wrong model.
That the Bayesian, like the classical frequentist, can be wrong, that both need to look at the data to avoid being wrong, to look at the data to judge whether their assumptions are reasonable and their models are adequate -this need to look at the data -is a strength of the Bayesian and classical frequentist perspectives, not a weakness.
Standardized Mortality Rates For Public Reporting
After modeling mortality rates as a function of hospital and patient attributes, the next major step in preparing hospital rate estimates for public reporting and further analysis, is to remove patient case-mix effects with some form of standardization. Devoid of differences due to patient risk factors, such estimates allow for much clearer assessments of hospital quality. In this vein, Hospital Compare employs a form of indirect standardization for their (C,C) model estimates.
As an alternative, we propose a direct standardization approach that more successfully eliminates patient case-mix effects over a wider range of models, and is better calibrated with the actual overall observed mortality rates. Let us proceed to describe and illustrate these two different approaches in detail.
To begin with, both standardization approaches make use of expected mortality rate estimates for any patient at any hospital. If the hjth patient with covariates x hj had been treated at hospital h * , under any of our models this rate would be given by
where α h * is now the hospital effect and x hj β is the usual patient effect. Note that unless h * = h, this rate is counterfactual, since patient hj was actually treated at hospital h. Note also that for models which include patient-hospital interactions, these interaction covariates would be included as extra columns of x hj that change as h * is varied. For example, in our (SLI,L) model, age hj * log(vol h * ) would be the added interaction covariate for patient hj at hospital h * . Rather than add cumbersome notation to indicate such dependence of x hj on h * , for notational simplicity we shall assume that this dependence is implicitly understood from context.
Indirectly Standardized Mortality Rates
As discussed by Ash et al. (2012) , as part of its mandate, CMS is charged with quantifying "How does this hospital's mortality for a particular procedure compare to that predicted at the national level for the kinds of patients seen for that procedure or condition at this hospital?" To address this goal, Hospital Compare reports estimates of indirectly standardized hospital mortality rates of the form
where E h is an average expected 30-day mortality rate for the hospital h patients had they been treated at the"national level", andȳ is the overall average patient-level mortality rate estimate for AMI. Beyond its intuitive appeal, strictly speaking, P IS h lacks any probabilistic justification as a hospital mortality rate estimate.
For their choice of E h in conjunction with the (C,C) model, Hospital Compare uses
where for patient j at hospital h, p µ (x hj ) = logit −1 (µ α + x hj β) replaces the hospital effect α h in p hj = logit −1 (α h + x hj β) with the mean hospital effect µ α from (2.2). As opposed to p hj ,p µ (x hj ) treats every patient as if they went to a hospital with the same average mortality effect µ α . To estimate E HC h , Hospital Compare uses SAS's GLIMMIX plug-in estimates of µ α and β, (Yale New Haven Health Services Corporation 2014, p. 58, equation (4)).
Although the choice of E HC h for E h is reasonable, it is tied directly to the Hospital Compare (C,C) model (2.2) through µ α . To extend indirect standardization beyond the (C,C) model, we propose instead a more flexible and general choice of E h that essentially reduces to E HC h under the (C,C) model. Our proposal, which is generally applicable for all the models considered in Section 3, is
where from (5.1), p h * (x hj ) is the expected mortality rate for the hjth patient, had they been treated at hospital h * . Intuitively, E h is the average expected mortality rate of all hospital h patients had they hypothetically been treated at all hospitals, h * = 1, . . . , H. Such averaging over all hospitals removes hospital-to-hospital variation, leaving only the patient attributes to drive the variation of E h . With this choice of E h , posterior mean Bayes estimatesP IS h of P IS h in (5.2) are straightforwardly obtained via the MCMC approach in Section A.1.
Making use of the fact that logit(·) is close to linear in the range of most mortality rates here, insight into how E h works, as well as its connection with E HC h , is obtained by the approximation
Recall that x hj will vary over h * when patienthospital interaction covariates are present. In models with no patient-hospital interactions, wherē x hj = x hj , E h essentially treats every patient as if they went to a hospital with the same average mortality effectᾱ. In particular, under the (C,C) model whereᾱ ≈ µ α in (5.3), E h will be nearly identical to the Hospital Compare choice E HC h . As a computational shortcut, (5.5) also provides a convenient route to obtain fast approximations for general E h .
To see the effect of the indirect standardization (5.2) with (5.4) for the (C,C), (L,C), (S,L), (SLI,I) models, we apply it to obtain the indirectly standardized mortality rate estimatesP IS h in Figures 5.1abcd . In each these plots,P IS h has served to transform the mortality rate estimatesP h in Figures 
When the α h are far fromᾱ, as occurs for low volume hospitals under the (L,C), (S,L) and (SLI,L) models, the variation of (5.6) will reflect the variation of patient attributes x hj across hospitals, especially when n h is small. Thus, under these models, the increased variation of theP IS h at the low volume hospitals is an artifact of patient-mix variation rather than of theα h hospital quality variation. Although this phenomenon does not occur under the (C,C) model where all the low volumeα h 's are close toᾱ, this is precisely where theα h 's estimates were seen to be miscalibrated. For all but the discredited (C,C) model, indirect standardization fails to achieve its goal of eliminating the effect of patient case-mix variation from mortality rates. Furthermore, as we'll see in the next section, for every one of our models, indirectly standardized mortality rates systemically underestimate actual mortality rates. Such indirect standardization cannot be recommended for public reporting.
Directly Standardized Mortality Rates
Directly standardized mortality rates, an alternative to P IS h , directly eliminate patient-mix effects by averaging the mortality rates of all patients had they (hypothetically) been been treated at hospital h. Denoted P DS h , such rates are given by
where p h (x h * j ) in (5.1) is the h * jth patient's mortality rate had they been treated at hospital h, and N = H i=1 n i is the total number of patients. Because every P DS h is an average over the same set of all patients, there can be no patient-mix differences between them. Note how P DS h is complementary to P IS h , which instead adjusts P h by E h , the average mortality rate of hospital h patients had they (hypothetically) been treated at all hospitals. Posterior mean Bayes estimateŝ Further insight into P DS h is obtained by the approximation
, which follows from the fact that logit(·) is close to linear in the range of most mortality rates here. Thus, P DS h may be regarded as the expected mortality rate at hospital h of a patient with averagex ·· attributes. In models with no patient-hospital interactions (where x h * j does not vary with h),x ·· is simply the mean of x h * j over all patients. rates, while the lower line is the same observed average mortality ratē y = 0.1498 obtained by averaging over all patients in our data. By the indirect standardization construction, the simple average of theP IS h rates will always equal the average patient mortality rateȳ, as is evident in their plots. In fact, theP IS h rates understate the poor performance of the worst hospitals by overstating the risk faced by the typical patient as the following discussion will show.
As we have seen, low volume hospitals have higher than typical risk, but treat relatively few patients; therefore, the (unweighted) average risk over hospitals is much higher than the average risk faced by patients. Saying the same thing differently, a random patient likely went to a larger volume hospital -that's what it means to be a larger volume hospital -but a random hospital is unlikely to have very high volume -that's what it means to be a random hospital. The expected risk E h used byP IS h in approximation (5.5) is essentially obtained by substituting the average hospital effectᾱ for the specific hospital effect α h in the various expressions for patient mortality rates. This average hospital effectᾱ describes the typical hospital, not the hospital that treats the typical patient. Therefore, E h is too high: it describes the risk that would be relevant if patients picked hospitals at random with equal probabilities, but they don't; rather, they tend to go to larger volume hospitals with lower risk. This one problem withP IS h could be fixed with a patch: instead of using the unweightedᾱ, one could average over hospitals with weights proportional to their volumes; that would describe the risk faced by the typical patient. However, this would still not resolve the patient-mix variability shortcomings ofP IS h discussed in the previous section. Overall, we recommendP DS h overP IS h as a more reliable standardized mortality rate report, especially for the model elaborations that we have proposed. Thus, the systematically higher mortality rate estimates at low volume hospitals under our models, are also each less precise or reliable in the sense that there is more uncertainty about their accuracy. Figure 6 .1 reminds us that in judging the mortality rate estimate for a given hospital with our models, consideration must given both to the point estimate and its uncertainly as reflected by the posterior distribution. In particular, if a small hospital was plausibly excellent, an analysis of this form would convey that such excellence is plausible.
Hospital Classification by Mortality Rates
Do many or few hospitals have high mortality rates compared to national rates? The 95% credibility intervals for P DS h described in the previous section can be used to classify hospitals as Low, Average, or High mortality according to whether its 95% interval is entirely below, intersects oris entirely above the overall average morality rate of 15%. 
The Influence of Hospital Attributes
The ( 
Discussion
As a model for AMI hospital mortality rates, we have found the hierarchical random effect logit model used by Hospital Compare to be inadequate compared to alternatives that model hospital effects as a functions of hospital attributes. Such models were seen to offer substantial predictive improvements as measured by out-of-sample predictive Bayes factors. Going further, we have suggested calibrating individualized predictions from Bayesian models against empirically based general advice that would otherwise be used to inform decisions. This entails conducting an outof-sample study of general advice without using the model, and then using the model to predict the results of that independent study. For this purpose, a matched out-of-sample comparison confirmed familiar advice that low volume hospitals tend to have higher mortality rates when treating AMI. While our models accurately predicted the results of that matched out-of-sample study, the current Hospital Compare model is not calibrated in this sense, and hence should not be used.
One of the main goals of this paper has been to show that the inclusion of hospital attributes in our models leads to better calibrated and more informative mortality rate predictions. In particular, we obtained a vast improvement over the Hospital Compare model with the Medicare data by including hospital volume, staffing by nurses and residents, PCI, and patient-age by hospital-volume interactions. While this improvement better serves the needs of patients, its ramifications for public policy must be considered cautiously. Because low volume hospitals, by definition, have little data regarding mortality, a better small volume hospital may be unable to overcome the poor results of its similarly sized peers to receive the good ranking it deserves. To some extent, this problem can be mitigated with our models, by including measures of uncertainty along with mortality rate estimates, as described in Section 6.1. However, further modeling with additional hospital attributes has the clear potential to shed more light on the rankings of such hospitals. In particular, the addition of hospital attributes which distinguish better low volume hospitals from the rest would be ideal. Indeed, our models should be considered as the beginning rather than the end of the story. While hospital volume is a convenient variable which is strongly associated with mortality, with more information for example about hospital management, it may even turn out not to be the most important predictive variable, thereby diminishing its penalizing effect.
We have also recommended that the common practice of reporting indirectly standardized rates be avoided. We found that that for our improved models, indirectly standardized rates fail to eliminate the effect of patient mix differences across hospitals. Furthermore, such indirectly adjusted rates are also inherently misleading in that they systematically underestimate population hospital mortality rates. In contrast, direct adjustment faithfully translates the model's adjustments and mortality predictions into a properly calibrated and easily understood format for public reporting.
The future lies with predictions that are individualized not just to particular hospitals, but to particular patients when treated at particular hospitals. We scratched the surface of this topic by including patient-by-hospital interactions in (5.1), finding that younger Medicare patients benefit more that older Medicare patients from treatment at high volume hospitals. Note that once we have fit one of our models and obtained estimates of the α h and β, (5.1) can be applied with p h (x) for any patient characteristics x to obtain mortality rate estimates for that patient at any hospital. Such personalized rate estimates would be more relevant than standardized rates for any particular patient.
Supplementary Materials
As To describe the simulation of α and β, let X be the complete matrix of patient attributes, K be the block diagonal matrix of hospital indicators, Ω = diag(ω) and κ = Ω −1 (Y − 0.5). Then, simulation from π(α | Y , ω, β, ψ) is obtained by simulating
where
Finally, simulation from π(ψ | Y , ω, α, β), which does not depend on ω, is obtained by well known routine methods and so will not be further discussed here.
Starting with initial values, successive substitution sampling from these distributions after a suitable burn-in period and with appropriate thinning, yields a sequence 
A.2 Modeling α h as a Linear Function of the Number of Beds
All of our models have made use of the strong apparent relationship between hospital mortality and vol. To get further insight into the relationship between mortality rates and hospital size, we also examined the relationship between mortality rates and the hospital attribute beds2008, the number of beds in 2008, a variable that is indisputably exogenous to our observed mortality rates.
Analogous to Figure 2 .1, Figure A .1 plots the raw observed mortality rates O h versus beds2008 h .
As summarized by the superimposed smoothing spline, the average mortality rate is decreasing as beds2008 increases. Note that many hospitals have the same value of beds2008. For example, 741 hospitals had beds2008 = 25, which was the modal number in our data. 
A.3 A Second Calibration with the US News and World Report Rankings
To further illustrate our method of matched comparison in Section 4.2, we did a second calibration following the same format which we here describe briefly. The popular magazine, US News and World Report, ranks hospitals on their "heart and heart surgery" program. We repeated the observational study of low volume hospitals, replacing low volume hospitals by the top ten hospitals in the US News and World Report ranking. In the six-month validation sample, there were 816 AMI patients in Medicare treated at the top ten hospitals in this ranking, and we matched them 5-to-1 to patients from other hospitals, checking covariate balance in parallel with Table 4 .2. Unlike Table 4 .2, the patients at "top ten" hospitals were not very different from all patients prior to admission. The matched comparison estimated about 2.0% lower mortality at "top ten" hospitals compared to matched controls without using the Bayes models. The Bayes models all predicted lower mortality at "top ten" hospitals than at control hospitals, but they slightly underestimated the 2.0% gain; for instance, the (SLI,L) model estimated 1.7% lower mortality at "top ten" hospitals. 
A.4 Hospital Cross Classification by Mortality Rates
